Literature DB >> 19495540

Is Burch or mid-urethral sling better with abdominal sacral colpopexy?

Minita Patel1, David O'Sullivan, Paul K Tulikangas.   

Abstract

INTRODUCTION AND HYPOTHESIS: This study aims to compare the post-operative rates of stress urinary incontinence (SUI) after abdominal sacral colpopexy (ASC) with either Burch or mid-urethral sling, tension-free vaginal tape (TVT), or no anti-incontinence procedure. The null hypothesis was there would be no difference in SUI among groups.
METHODS: A cohort of women who had undergone ASC (n = 150) either alone or with an anti-continence procedure were analyzed to determine the rates of post-operative SUI. Statistically significant differences were evaluated with a Student's t-test.
RESULTS: A total of 150 subjects were evaluated, with 115 having SUI preoperatively. Post-operatively, 10% (15/150) of all subjects had SUI. Subjects with preoperative SUI who had a Burch were more likely to have post-operative SUI than those who had a TVT (10 versus 0, p = 0.007).
CONCLUSIONS: Burch and TVT procedures improve SUI symptoms in patients undergoing ASC. Mid-urethral slings performed with ASC have lower rates of post-operative SUI.

Entities:  

Mesh:

Year:  2009        PMID: 19495540     DOI: 10.1007/s00192-009-0861-6

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  7 in total

1.  The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction.

Authors:  R C Bump; A Mattiasson; K Bø; L P Brubaker; J O DeLancey; P Klarskov; B L Shull; A R Smith
Journal:  Am J Obstet Gynecol       Date:  1996-07       Impact factor: 8.661

2.  Abdominal sacrocolpopexy with Burch colposuspension to reduce urinary stress incontinence.

Authors:  Linda Brubaker; Geoffrey W Cundiff; Paul Fine; Ingrid Nygaard; Holly E Richter; Anthony G Visco; Halina Zyczynski; Morton B Brown; Anne M Weber
Journal:  N Engl J Med       Date:  2006-04-13       Impact factor: 91.245

3.  Tension-free vaginal tape (TVT) for the treatment of occult stress urinary incontinence in women undergoing prolapse repair: a prospective study of 100 consecutive cases.

Authors:  Asnat Groutz; Ronen Gold; David Pauzner; Joseph B Lessing; David Gordon
Journal:  Neurourol Urodyn       Date:  2004       Impact factor: 2.696

4.  Combined genital prolapse repair reinforced with a polypropylene mesh and tension-free vaginal tape in women with genital prolapse and stress urinary incontinence: a retrospective case-control study with short-term follow-up.

Authors:  Renaud de Tayrac; Amelie Gervaise; Aurelia Chauveaud-Lambling; Herve Fernandez
Journal:  Acta Obstet Gynecol Scand       Date:  2004-10       Impact factor: 3.636

5.  Two-year outcomes after sacrocolpopexy with and without burch to prevent stress urinary incontinence.

Authors:  Linda Brubaker; Ingrid Nygaard; Holly E Richter; Anthony Visco; Anne M Weber; Geoffrey W Cundiff; Paul Fine; Chiara Ghetti; Morton B Brown
Journal:  Obstet Gynecol       Date:  2008-07       Impact factor: 7.661

6.  One-year urodynamic outcome and quality of life in patients with concomitant tension-free vaginal tape during pelvic floor reconstruction surgery for genitourinary prolapse and urodynamic stress incontinence.

Authors:  M W Pang; L W Chan; S K Yip
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-08-23

7.  Three surgical procedures for genuine stress incontinence: five-year follow-up of a prospective randomized study.

Authors:  A Bergman; G Elia
Journal:  Am J Obstet Gynecol       Date:  1995-07       Impact factor: 8.661

  7 in total
  2 in total

1.  Urinary incontinence: treating occult SUI-are two steps better than one?

Authors:  Ali-Reza Sharif-Afshar; Jennifer Anger
Journal:  Nat Rev Urol       Date:  2012-10-09       Impact factor: 14.432

Review 2.  Should an anti-incontinence procedure be routinely performed at the time of pelvic organ prolapse repair? An evidence-based review.

Authors:  Humphrey O Atiemo
Journal:  Curr Urol Rep       Date:  2010-09       Impact factor: 3.092

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.